Publication number: 20220133833
Abstract: The invention relates to RAAS Nutritionals food functional dietary supplements derived from soybean (Glycine max), grape (vitis vinifera) and rice (Oryza sativa) for prophylaxis and therapeutic treatment of virus SARS-CoV-2, Acinetobacter baumanii, Bordetella pertussis, parapertusis, bronchiseptica, Chlamydia trachomatis, Coronavirus-299E, Coronavirus NL63, Coronavirus OC43, Coronavirus HKU1, Cytomegalovirus CMV, Cytomegalovirus Human Herpesvirus-5, Enterobacter aerogenes, Enterobacter cloacae, Enterovirus D, Fusobacterium nucleatum, Fusobacterium necrophorum, Herpes simplex virus 1 (HSV-1), Herpes simplex virus 2 (HSV-2), Human metapneumovirus, Klebisella pneumoniae, Klebisella oxytoca, Moraxella catarrhalis, Meisseria gonorrhoeae, Proteus mirabilis, Proteus vulgaris, Respiratory syncytial virus, Serratia marcescens, Staphylococcus aureus, Streptococcus pneumoniae, Treponema pallidum, CTX-M1 (15), CTX-M2 (2), CTX-M9 (9), CTX-M8/25 groups, ermB, ermC, mefA, mecA, Per-lNEB-1/GES-1 Groups, SHV, KPC Groups, VanA
Type:
Application
Filed:
July 8, 2021
Publication date:
May 5, 2022
Inventor:
Kieu Hoang